The DOI matches its Crossref record; 22 of the 22 references it cites were found in a registry or an index.
Akt induces enhanced myocardial contractility and cell size in vivo in transgenic mice
Open accessAbstract
The serine-threonine kinase Akt seems to be central in mediating stimuli from different classes of receptors. In fact, both IGF-1 and IL6-like cytokines induce hypertrophic and antiapoptotic signals in cardiomyocytes through PI3K-dependent Akt activation. More recently, it was shown that Akt is involved also in the hypertrophic and antiapoptotic effects of β-adrenergic stimulation. Thus, to determine the effects of Akt on cardiac function in vivo , we generated a model of cardiac-specific Akt overexpression in mice. Transgenic mice were generated by using the E40K, constitutively active mutant of Akt linked to the rat α-myosin heavy chain promoter. The effects of cardiac-selective Akt overexpression were studied by echocardiography, cardiac catheterization, histological and biochemical techniques. We found that Akt overexpression produced cardiac hypertrophy at the molecular and histological levels, with a significant increase in cardiomyocyte cell size and concentric LV hypertrophy. Akt-transgenic mice also showed a remarkable increase in cardiac contractility compared with wild-type controls as demonstrated by the analysis of left ventricular (dP/dt max ) in an invasive hemodynamic study, although with graded dobutamine infusion, the maximum response was not different from that in controls. Diastolic function, evaluated by left ventricular dP/dt min , was not affected at rest but was impaired during graded dobutamine infusion. Isoproterenol-induced cAMP levels, β-adrenergic receptor (β-AR) density, and β-AR affinity were not altered compared with control mice. Moreover, studies on signaling pathway activation from myocardial extracts demonstrated that glycogen synthase kinase3-β is phosphorylated, whereas p42/44 mitogen-activated protein kinases is not, indicating that Akt induces hypertrophy in vivo by activating the glycogen synthase kinase3-β/GATA 4 pathway. In summary, our results not only demonstrate that Akt regulates cardiomyocyte cell size in vivo , but, importantly, show that Akt modulates cardiac contractility in vivo without directly affecting β-AR signaling capacity.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
AKT plays a central role in tumorigenesis
Testa, J. R., & Bellacosa, A. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.211430998 · Cited by 944
Self-citationFujio, Y., Nguyen, T., Wencker, D., Kitsis, R. N., & Walsh, K. (2000) · Circulation · doi:10.1161/01.cir.101.6.660 · Cited by 847
Arber, S., Hunter, J. J., Ross, J., Hongo, M., Sansig, G., Borg, J., Perriard, J.-C., Chien, K. R., & Caroni, P. (1997) · Cell · doi:10.1016/s0092-8674(00)81878-4 · Cited by 838
Self-citationLuo, W., Grupp, I. L., Harrer, J., Ponniah, S., Grupp, G., Duffy, J. J., Doetschman, T., & Kranias, E. G. (1994) · Circulation Research · doi:10.1161/01.res.75.3.401 · Cited by 706
Matsui, T., Tao, J., del Monte, F., Lee, K.-H., Li, L., Picard, M., Force, T. L., Franke, T. F., Hajjar, R. J., & Rosenzweig, A. (2001) · Circulation · doi:10.1161/01.cir.104.3.330 · Cited by 701
The conserved phosphoinositide 3-kinase pathway determines heart size in mice
Shioi, T. (2000) · The EMBO Journal · doi:10.1093/emboj/19.11.2537 · Cited by 604
Akt activation by growth factors is a multiple-step process: the role of the PH domain
Bellacosa, A., Chan, T. O., Ahmed, N. N., Datta, K., Malstrom, S., Stokoe, D., McCormick, F., Feng, J., & Tsichlis, P. (1998) · Oncogene · doi:10.1038/sj.onc.1201947 · Cited by 547
Self-citationActivated glycogen synthase-3β suppresses cardiac hypertrophy in vivo
Antos, C. L., McKinsey, T. A., Frey, N., Kutschke, W., McAnally, J., Shelton, J. M., Richardson, J. A., Hill, J. A., & Olson, E. N. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.231619298 · Cited by 477
Zhu, W.-Z., Zheng, M., Koch, W. J., Lefkowitz, R. J., Kobilka, B. K., & Xiao, R.-P. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.98.4.1607 · Cited by 464
WLuo, LGrupp, I., JHarrer, SPonniah, GGrupp, JDuffy, J., TDoetschman, & GKranias, E. (1994) · Circulation Research · Cited by 403
Condorelli, G., Borello, U., De Angelis, L., Latronico, M., Sirabella, D., Coletta, M., Galli, R., Balconi, G., Follenzi, A., Frati, G., et al. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.191217898 · Cited by 367
Self-citationTransthoracic Echocardiography in Models of Cardiac Disease in the Mouse
Tanaka, N., Dalton, N., Mao, L., Rockman, H. A., Peterson, K. L., Gottshall, K. R., Hunter, J. J., Chien, K. R., & Ross, J. (1996) · Circulation · doi:10.1161/01.cir.94.5.1109 · Cited by 364
Self-citationHunter, J. J., Tanaka, N., Rockman, H. A., Ross, J., & Chien, K. R. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.39.23173 · Cited by 312
Self-citationThe left ventricular dP/dtmax-end-diastolic volume relation in closed-chest dogs.
Little, W. C. (1985) · Circulation Research · doi:10.1161/01.res.56.6.808 · Cited by 297
Condorelli, G., Morisco, C., Stassi, G., Notte, A., Farina, F., Sgaramella, G., de Rienzo, A., Roncarati, R., Trimarco, B., & Lembo, G. (1999) · Circulation · doi:10.1161/01.cir.99.23.3071 · Cited by 282
Self-citationMorisco, C., Zebrowski, D., Condorelli, G., Tsichlis, P., Vatner, S. F., & Sadoshima, J. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.275.19.14466 · Cited by 258
Self-citationGlycogen Synthase Kinase 3β Regulates GATA4 in Cardiac Myocytes
Morisco, C., Seta, K., Hardt, S. E., Lee, Y., Vatner, S. F., & Sadoshima, J. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m103166200 · Cited by 232
Self-citationOh, H., Fujio, Y., Kunisada, K., Hirota, H., Matsui, H., Kishimoto, T., & Yamauchi-Takihara, K. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.16.9703 · Cited by 211
Condorelli, G., Roncarati, R., Ross, J., Pisani, A., Stassi, G., Todaro, M., Trocha, S., Drusco, A., Gu, Y., Russo, M. A., et al. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.161120198 · Cited by 171
Self-citationThe Tumor Suppressor Gene PTEN Can Regulate Cardiac Hypertrophy and Survival
Schwartzbauer, G., & Robbins, J. M. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m102479200 · Cited by 146
Zheng, M., Zhang, S.-J., Zhu, W., Ziman, B. D., Kobilka, B. K., & Xiao, R. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.m006325200 · Cited by 126
β-Adrenergic Receptor Kinase-1 Levels in Catecholamine-Induced Myocardial Hypertrophy
Iaccarino, G., Dolber, P. C., Lefkowitz, R. J., & Koch, W. J. (1999) · Hypertension · doi:10.1161/01.hyp.33.1.396 · Cited by 79
Self-citation
Cited by
Regulation of cardiac hypertrophy by intracellular signalling pathways
Heineke, J., & Molkentin, J. D. (2006) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm1983 · Cited by 1,866
MicroRNA-133 controls cardiac hypertrophy
Carè, A., Catalucci, D., Felicetti, F., Bonci, D., Addario, A., Gallo, P., Bang, M.-L., Segnalini, P., Gu, Y., Dalton, N. D., et al. (2007) · Nature Medicine · doi:10.1038/nm1582 · Cited by 1,776
Self-citationShiojima, I. (2005) · Journal of Clinical Investigation · doi:10.1172/jci24682 · Cited by 939
Chronic inhibition of cyclic GMP phosphodiesterase 5A prevents and reverses cardiac hypertrophy
Takimoto, E., Champion, H. C., Li, M., Belardi, D., Ren, S., Rodriguez, E. R., Bedja, D., Gabrielson, K. L., Wang, Y., & Kass, D. A. (2005) · Nature Medicine · doi:10.1038/nm1175 · Cited by 903
Bernardo, B. C., Weeks, K. L., Pretorius, L., & McMullen, J. R. (2010) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2010.04.005 · Cited by 894
Metadata
- Authors
- Condorelli, G., Drusco, A., Stassi, G., Bellacosa, A., Roncarati, R., Iaccarino, G., Russo, M. A., Gu, Y., Dalton, N., Chung, C., Latronico, M. V. G., Napoli, C., Sadoshima, J., Croce, C. M., & Ross, J.
- Venue
- Proceedings of the National Academy of Sciences
- Published
- 2002-09-17
- Volume
- 99
- Issue
- 19
- Pages
- 12333-12338
- ISSN
- 0027-8424 (ISSN-L)
- 1091-6490
- OpenAlex
- W2132136466
- Cited by
- 461
- References
- 22
- FWCI
- 9.18
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.